ATRA : Insider Transactions for Atara Biotherapeutics, Inc. | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Atara Biotherapeutics, Inc. (ATRA)

$0.67

0.02 (3.03%) as of 4:30 Fri 5/3

Download

Exchange:

N/A

Security Type:

N/A

Shares Out:

108,674,000

Market Cap:

72.81(M)

Last Volume:

0

Avg Vol:

0

52 Week Range:

$0.2298 - $2.97

Level I Sector:

N/A

Level II Sector:

N/A

Level III Sector:

N/A

Member Indexes:

Rankings:

Insider 3 Months : -

Insider 6 Months : 9.4

Insider 3/6 Months : 10

Guru Rank Number : 707

Guru Rank Value : 1.9

Guru Occurances : 1


6 Months 1 Year 2 Year

Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	816,825	816,825	816,825
Total Buy Value	$0	$194,885	$194,885	$194,885
Total People Bought	0	3	3	3
Total Buy Transactions	0	4	4	4
Total Shares Sold	56,192	121,276	273,751	412,845
Total Sell Value	$40,460	$65,778	$342,884	$1,024,948
Total People Sold	5	6	7	9
Total Sell Transactions	5	11	22	41
End Date	2024-02-04	2023-11-03	2023-05-05	2022-05-05

Adjust Filter Settings

Records found: 731

Page 10 of 30

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

SVP, Head of Global Commercial

• – –

2019-02-15

4

OE

$14.30

$57,200

D/D

4,000

27,597

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-02-15

4

D

$40.45

$47,569

D/D

(1,176)

332,243

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-02-12

4

AS

$39.01

$152,139

I/I

(3,900)

342,138

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-02-11

4

AS

$38.52

$150,228

I/I

(3,900)

346,038

-

Haqq Christopher

EVP, R&D & Chief Scientific Of

• – –

2019-02-11

4

AS

$38.55

$538,736

D/D

(13,975)

272,718

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-02-09

4

D

$38.49

$782,271

D/D

(20,324)

334,618

-

Global Head of R&D

• – –

2019-02-06

4

A

$0.00

$0

D/D

25,000

75,000

-

Haqq Christopher

EVP, R&D & Chief Scientific Of

• – –

2019-02-06

4

A

$0.00

$0

D/D

15,000

286,693

-

Haqq Christopher

EVP, R&D & Chief Scientific Of

• – –

2019-02-06

4

D

$38.47

$58,167

D/D

(1,512)

271,693

-

Haqq Christopher

EVP, R&D & Chief Scientific Of

• – –

2019-02-06

4

AS

$38.04

$477,922

D/D

(12,375)

273,205

-

Chief Financial Officer

• – –

2019-02-06

4

A

$0.00

$0

D/D

17,063

64,063

-

SVP, Head of Global Commercial

• – –

2019-02-06

4

A

$0.00

$0

D/D

12,313

23,597

-

SVP, Head of Global Commercial

• – –

2019-02-06

4

D

$38.47

$46,780

D/D

(1,216)

11,284

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-02-06

4

D

$0.00

$0

D/D

(24,683)

375,611

-

Chief Tech. Operations Officer

• – –

2019-02-06

4

A

$0.00

$0

D/D

17,500

47,146

-

Chief Tech. Operations Officer

• – –

2019-02-06

4

D

$38.47

$85,096

D/D

(2,212)

29,646

-

Senior VP & General Counsel

• – –

2019-02-06

4

A

$0.00

$0

D/D

17,063

60,063

-

Chief Tech. Operations Officer

• – –

2019-02-02

4

AS

$38.44

$19,220

D/D

(500)

31,858

-

Chief Tech. Operations Officer

• – –

2019-02-01

4/A

AS

$38.44

$19,220

D/D

(500)

31,858

-

Chief Tech. Operations Officer

• – –

2019-02-01

4

AS

$37.80

$37,800

D/D

(1,000)

32,358

-

Chief Tech. Operations Officer

• – –

2019-02-01

4

OE

$20.40

$30,600

D/D

1,500

33,358

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-01-24

4

AS

$34.98

$136,783

I/I

(3,900)

296,452

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-01-23

4

AS

$34.84

$136,650

I/I

(3,900)

300,352

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-01-10

4

AS

$33.93

$133,581

I/I

(3,900)

4,078

-

Ciechanover Isaac E.

Chief Executive Officer

• • –

2019-01-09

4

AS

$34.51

$135,889

I/I

(3,900)

7,978

-

731 Records found	Previous 10 11 12 13 14 15 16 17 18 19 Next	Page 10 of 30

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.